Lowella Esperanza, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 38051 Market Square, Zephryhills, FL 33542 Phone: 813-780-8085 Fax: 813-355-5042 |
News Archive
Several of the world's most eminent health scientists and organizations today publish a landmark global consensus on the 20 foremost measures needed to curb humanity's most fatal diseases, their study featured in Nature magazine.
Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to research funded by Cancer Research UK and published in the Journal of the National Cancer Institute today (Thursday).
TIME reports that states "could have a surprising degree of autonomy in determining how they implement" federal health reforms. "Though most everyone recognizes that the federal government can't impose a rigid approach, some critics say that the crucial version of legislation expected to pass Senator Max Baucus' Finance Committee in the next week ... may go too far in the other direction."
The researcher Gabriela Debesa, member of the research group at Simbiosis led by Andrés Moya at the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (Fisabio), studied the relationship of the intestinal microbiota with colon cancer in patients with Lynch Syndrome (a hereditary illness that predisposes the development of cancer) using tissue samples in formalin and conserved in paraffin.
Medopad today announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and potentially commercialize the ReVeRe platform as a novel digital biomarker for Alzheimer's disease. This deal was facilitated by Johnson & Johnson Innovation Limited.
› Verified 1 days ago